| Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia RE van Weelderen, CJ Harrison, K Klein, Y Jiang, J Abrahamsson, ... Blood Advances 8 (12), 3200-3213, 2024 | | 2024 |
| Acute lymphoblastic leukaemia L Pagliaro, SJ Chen, D Herranz, C Mecucci, CJ Harrison, CG Mullighan, ... Nature Reviews Disease Primers 10 (1), 1-28, 2024 | | 2024 |
| A dedicated caller for DUX4 rearrangements from whole-genome sequencing data P Grobecker, S Berri, JF Peden, KJ Chow, C Fielding, I Armogida, ... bioRxiv, 2024.05. 23.595509, 2024 | | 2024 |
| A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study A Enshaei, M Joy, E Butler, AA Kirkwood, M Messina, C Pavoni, ... Blood Advances 8 (5), 1155-1166, 2024 | | 2024 |
| A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study A Enshaei, M Joy, E Butler, AA Kirkwood, M Messina, C Pavoni, ... Blood Advances 8 (5), 1155-1166, 2024 | | 2024 |
| Genetic alterations in lymphoblastic leukaemia / lymphoma – a practical guide to WHO HAEM5 D Steinemann, M Dawidowska, LJ Russell, CJ Harrison, G Göhring Medizinische Genetik 36 (1), 39-45, 2024 | | 2024 |
| Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias C Mark, S Meshinchi, B Joyce, B Gibson, C Harrison, AK Bergmann, ... British Journal of Haematology 204 (2), 576-584, 2024 | 2 | 2024 |
| Outcomes for Children with High Risk Acute Myeloid Leukemia on the Myechild 01 International Phase III Clinical Trial A Moore, S Maycock, G Leverger, O Smith, A Baruchel, Y Bertrand, ... Blood 142, 730, 2023 | | 2023 |
| Correction:“The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul; 36 (7): 1720–1748 R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle, ... Leukemia 37 (9), 1944-1951, 2023 | 4 | 2023 |
| The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 Q Gao, SL Ryan, I Iacobucci, PS Ghate, RE Cranston, C Schwab, ... Blood 142 (8), 711-723, 2023 | 13 | 2023 |
| Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia D Leongamornlert, J Gutiérrez-Abril, SW Lee, E Barretta, T Creasey, ... Blood Advances 7 (15), 3862-3873, 2023 | 9 | 2023 |
| Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A … RE van Weelderen, K Klein, CJ Harrison, Y Jiang, J Abrahamsson, ... Journal of Clinical Oncology 41 (16), 2963-2974, 2023 | 21 | 2023 |
| Health, education, and social care provision after diagnosis of childhood visual disability AL Solebo, LJ Teoh, J Sargent, JS Rahi, ... Developmental Medicine & Child Neurology 65 (6), 803-810, 2023 | 1 | 2023 |
| Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement S Bomken, A Enshaei, EC Schwalbe, A Mikulasova, Y Dai, M Zaka, ... Haematologica 108 (3), 717, 2023 | 9 | 2023 |
| Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia PB Sinclair, RE Cranston, P Raninga, J Cheng, R Hanna, Z Hawking, ... Leukemia 37 (3), 636-649, 2023 | 1 | 2023 |
| Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial C Schwab, RE Cranston, SL Ryan, E Butler, E Winterman, Z Hawking, ... Leukemia 37 (3), 529-538, 2023 | 17 | 2023 |
| Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study A Attarbaschi, A Möricke, CJ Harrison, G Mann, A Baruchel, ... Journal of Clinical Oncology 41 (7), 1404-1422, 2023 | 16 | 2023 |
| Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia SL Ryan, JF Peden, Z Kingsbury, CJ Schwab, T James, P Polonen, ... Leukemia 37 (3), 518-528, 2023 | 36 | 2023 |
| Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working … K Ohki, ER Butler, N Kiyokawa, S Hirabayashi, AK Bergmann, A Möricke, ... Leukemia 37 (1), 212-216, 2023 | 9 | 2023 |
| Time to cure for childhood and young adult acute lymphoblastic leukemia is independent of early risk factors: long-term follow-up of the UKALL2003 trial AV Moorman, G Antony, R Wade, ER Butler, A Enshaei, CJ Harrison, ... Journal of Clinical Oncology 40 (36), 4228-4239, 2022 | 11 | 2022 |
Anthony MoormanProfessor of Genetic Epidemiology, Newcastle University在 newcastle.ac.uk 的电子邮件经过验证
Anthony MoormanProfessor of Genetic Epidemiology, Newcastle University在 newcastle.ac.uk 的电子邮件经过验证